SEC Form 4 · accession 0001104659-18-001494
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary S Jacob
Officer — Executive Chairman · Director
Period of report
Jan 5, 2018
Accepted (ET)
Jan 9, 2018 · 5:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $2.18 | Jan 5, 2018 | A | 950,000 | A | — | Jan 5, 2028 | Common Stock | 950,000 | 6,988,303 | D |
Explanation of responses
- F1316,667 options vest on each of 1/5/2019 and 2020 and 316,666 vest on 1/5/2021.